Literature DB >> 3753202

Chicken strain G-B1 exhibits a relative resistance to avian osteopetrosis.

J Böni, M Böni-Schnetzler, O Vainio, R M Franklin.   

Abstract

The disease induced by the avian myeloblastosis associated virus MAV-2-O in the susceptible chicken strains Brown Leghorn (BLH) and Prague CB (CB) was compared with that induced in the resistant G-B1 strain. Osteopetrosis, stunting and lymphoid organ atrophy were more severe in BLH than in CB chickens. G-B1 animals remained superficially normal until the end of the experiment. In contrast to the other two strains, the histopathological changes were very mild and there was no sign of immunosuppression. After 4 months, however, nephroblastomas could be detected in more than 50 per cent of the infected G-B1 chickens. Similar tumors were also found in CB birds kept for up to 5 months. Antibodies against MAV-2-O specific viral proteins were detected in plasma from infected G-B1 chickens but the titers were less than in plasma of convalescent birds. Virus could be demonstrated in peripheral blood until the end of the experiment (at 8 weeks). Therefore the resistance of the G-B1 strain is due neither to a restriction at the receptor level nor the result of a humoral immune reaction, but represents a new type of relative resistance at the cellular level. From (CC X G-B1)F1 and (CC X G-B1)F2 crosses the resistant phenotype is determined by a single genetic factor. This gene is not linked to the major histocompatibility complex. There is also a sex-dependent factor, possibly hormonal, involved in the resistant phenotype.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3753202     DOI: 10.1007/bf01316725

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  31 in total

1.  Postmortem findings in avian osteopetrosis.

Authors:  J R HOLMES
Journal:  J Comp Pathol       Date:  1961-01       Impact factor: 1.311

Review 2.  Two levels of genetic resistance to lymphoid leukosis.

Authors: 
Journal:  Avian Dis       Date:  1975 Apr-Jun       Impact factor: 1.577

3.  Avian leukosis virus-induced osteopetrosis is associated with the persistent synthesis of viral DNA.

Authors:  H L Robinson; B D Miles
Journal:  Virology       Date:  1985-02       Impact factor: 3.616

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  The oncogenic effects of nontransforming viruses from avian myeloblastosis virus.

Authors:  R E Smith; C Moscovici
Journal:  Cancer Res       Date:  1969-07       Impact factor: 12.701

6.  Staining and histochemistry of undecalcified bone embedded in a water-miscible plastic.

Authors:  R M Franklin; M T Martin
Journal:  Stain Technol       Date:  1980-09

7.  In ovo tumorigenesis induced by avian osteopetrosis virus.

Authors:  R M Franklin; M T Martin
Journal:  Virology       Date:  1980-08       Impact factor: 3.616

8.  Nomenclature for chicken major histocompatibility (B) complex.

Authors:  W E Briles; N Bumstead; D L Ewert; D G Gilmour; J Gogusev; K Hála; C Koch; B M Longenecker; A W Nordskog; J R Pink; L W Schierman; M Simonsen; A Toivanen; P Toivanen; O Vainio; G Wick
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

9.  Electron microscopy of the periosteum in experimental avian osteopetrosis.

Authors:  C F Simpson; V L Sanger
Journal:  Cancer Res       Date:  1966-04       Impact factor: 12.701

10.  Resistance to a malignant lymphoma in chickens is mapped to subregion of major histocompatibility (B) complex.

Authors:  W E Briles; R W Briles; R E Taffs; H A Stone
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

View more
  1 in total

1.  MAV-2-O replicates at a reduced rate in cells from the osteopetrosis resistant G-B1 chicken.

Authors:  J Böni; M Böni-Schnetzler; R M Frank; R M Franklin
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.